Table 1 Baseline characteristics of migraine patients and comparisons of treatment groups and of treatment groups with controls*

CharacteristicsNo. (%)Odds ratio (95% CI)
TMNMTM vs NMTM vs CTMNM vs CNM
* Adjusting for other variables in the table.
† Comparative analysis against no record of smoking status.
TM = triptan-treated migraine; NM = non-triptan-treated migraine; CTM = controls for triptan-treated migraine; CNM = controls for non-triptan-treated migraine; Hchol = hypercholesterolemia; OC = oral contraceptive.
Hypertension812 (5.9)3,323 (6.7)0.81 (0.74, 0.88)0.94 (0.86, 1.03)1.15 (1.09, 1.22)
Cardiac disease423 (3.1)2,249 (4.5)0.69 (0.62, 0.77)1.06 (0.94, 1.20)1.31 (1.22, 1.40)
Obesity1,368 (10.6)4,486 (11.6)0.83 (0.78, 0.89)1.00 (0.93, 1.08)1.17 (1.12, 1.23)
Hchol437 (3.2)1,377 (2.8)1.00 (0.90, 1.13)1.16 (1.03, 1.31)1.09 (1.00, 1.18)
Diabetes104 (0.8)54 (1.1)0.73 (0.59, 0.91)0.54 (0.44, 0.68)0.75 (0.67, 0.84)
OC use3,827 (35.1)12,608 (35.3)1.09 (1.03, 1.15)1.12 (1.06, 1.19)1.22 (1.18, 1.27)
Smoker1,810 (13.3)6,378 (12.8)0.97 (0.91, 1.04)1.47 (1.37, 1.58)1.57 (1.51, 1.64)
Non or ex-smoker8,577 (62.8)23,729 (47.5)1.28 (1.21, 1.35)1.82 (1.72, 1.92)1.52 (1.47, 1.57)
0–19 y938 (6.9)12,543 (25.1)0.03 (0.02, 0.05)1.58 (0.79, 3.14)1.51 (1.41, 1.62)
20–29 y1,991 (14.6)9,024 (18.1)0.46 (0.42, 0.51)1.26 (1.14, 1.39)1.32 (1.26, 1.38)
30–39 y3,371 (24.7)9,555 (19.1)1.63 (1.53, 1.73)0.99 (0.92, 1.06)1.01 (0.97, 1.06)
40–49 y4,158 (30.4)8,447 (16.9)2.33 (2.17, 2.49)1.02 (0.95, 1.09)1.05 (1.00, 1.10)
50–59 y2,273 (16.6)5,259 (10.5)2.12 (1.96, 2.29)1.01 (0.93, 1.10)1.02 (0.97, 1.08)
60–69 y688 (5.0)3,037 (6.1)1.17 (1.06, 1.31)1.01 (0.90, 1.14)1.00 (0.93, 1.06)
≥70 y245 (1.8)2,046 (4.1)0.64 (0.55, 0.75)1.04 (0.88, 1.4)0.99 (0.92, 1.07)
Men2,749 (20.1)14,177 (28.4)0.81 (0.77, 0.86)1.11 (1.05, 1.18)1.12 (1.09, 1.15)